ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Adaptive is Born

Harlan and his brother, Chad Robins, found Adaptive TCR to meet the demand for this technology from academic institutions around the world.

Propelling the Understanding of Adaptive Immunity

Dr. Harlan Robins, professor at the Fred Hutchinson Cancer Research Institute, and colleagues develop the first immunosequencing technology to profile the T-cell immune repertoire at scale and with precision, which had never before been possible.